Speaker 2017

list in progress…(25.02.2017)

Opening Lecture 2017

Keynote Lecture 2017

ah20120418137Philipp Jost, MD – Group Leader in Medical Clinic und Policlinic, Klinikum rechts der Isar, Munich

Philipp Jost´s area of interest is molecular medicine and immunology with a specific focus on the process of programmed cell death (termed apoptosis). His team wants to understand the function of pro-survival proteins from the Bcl-2 family for tumor cell initiation and tumor maintenance in the context of the whole organism. Another focus of his work is the non-apoptotic function of cell death proteins, especially from the inhibitor of apoptosis protein family (IAP) and their role in the immune system.
He studied Medicine in Berlin and Munich, defended his thesis (M.D.) in London and received his associate professorship (Habilitation) at the TUM. A postdoc fellowship from the Deutsche Krebshilfe brought him to Prof. A. Strasser at the Walter and Eliza Hall Institute for Medical Research in Melbourne, Australia. Since his return to the TUM, he is junior group leader of a Max Eder-Research Group funded by the Deutsche Krebshilfe at the III. Medical Department at the TUM.
At the echo Philipp Jost will be giving a presentation on ‚Leukemogenesis and Apopotosis‘.

Closing Lecture 2017


MarinaMarina Arendt, MScPhD student, Institute for Medical Informatics, Biometry and Epidemiology, Germany

Marina Arendt studied Molecular Biology at the University of Applied Sciences in Recklinghausen graduating to B.Sc. in 2011 with a thesis written at the University of Queensland in Brisbane, Australia. In her master studies she specialised in Bioinformatics and wrote her master thesis at the IMIBE where she is a research associate and PhD student since 2013. Her research focuses on genome wide association studies and geneset enrichment analyses in the topic of haematology especially MGUS and free light-chains.
At the echo Marina Arendt will be giving a presentation on ’statistical strategy and evaluation in medical research‘.

Bildschirmfoto 2017-02-01 um 20.05.53.pngPD. Klaus Griewank, MD – Assistant Physican and independent group leader for translational oncology research at the Department of Dermatology, University Hospital Essen

Klaus Griewank studied medicine in Jena, Berlin, Warsaw and Krakow. After he graduated his medical school in 2003 he started his doctoral dissertation at the Rheuma-Zentrum in Berlin until 2007. Griewank performed his training in Dermatology and research in Mainz, Chicago, New York and San Francisco. In November 2011 he became an independent group leader for translational oncology research at the Department of Dermatology at the University Hospital Essen. In 2014 he became his board license for Dermatology and in 2016 for Dermapathlogy.His research focuses on ‚Genetics of cutaneous and ocular neoplasms‘.
At the echo Klaus Griewank will be giving a presentation on ‚malignant melonoma‘.

009-datei

PD. Stefan Kasper, MD

 

Reinhardt_Dirk_18638.jpg

Prof. Dirk Reinhardt, MD – Direktor of the Clinic for Pediatric Oncology, University Hospital Essen

After his graduation from medical school in Göttingen in 1993 Dirk Reinhardt started his fellowship at the Children’s Hospital Göttingen (1994-1999). He also worked in Münster and Hannover before he recieved his professorship at the University Children’s Hospital Essen and became the Direktor of Pediatrics for Oncology and Hematology (2014). Furthermore he is the head of the working group for Pediatric Oncology (APO) which is founded by the GPOH and the German Cancer Society.
Dirk Reinhardt’s research focuses on the Pediatric Acute Myeloid Leukemia, leukemogenesis, stem cell biology as well as Clinical Trials and early drug development in Pediatric Hematology and Oncology. Therefore he is the Chair of the AML-BFM Study Group (AML-BFM 2004/2012) since 2009 and the Chair of the I-BFM-AML committee since 2012.
At the echo Dirk Reinhardt will be giving a presentation on ‚Pediatric Acute Myeloid Leukemia‘.

schlueter_HP2.jpgAnke Schlüter, MD – Assistant physician and part of the research division in the Clinic for Otorhinolaryngology, Head and Neck surgery University Hospital Essen
Anke Schlüter studied medicine in Düsseldorf and graduated from Medical School in 2012. She performed her training in Otorhinolaryngology, Head and Neck surgery in the University hospital in Essen. Currently she holds a position as an assistant physician and is part of the research division of the ENT clinic. Her research focuses on angiogenesis in Head and neck squamous cell carcinoma.
At the echo Anke Schlüter will be giving presentation on ‚head and neck cancer and especially the angiogenesis in laryngeal squamous cell carcinoma‘.

 Marc Schuster, PhD – PostDoc, Institute for Experimental Immunology and Imaging, ZMB, University Duisburg-Essen
At the echo Marc Schuster will be giving a presentation on ‚CRISPR/Cas9‘.

fittosize_230_0_1e6694252a74f5b16a212aa33c892d0f_window184Prof. Hendrik Streeck, MDDirector of the Institute of HIV Research, University Duisburg-Essen
Prof. Dr. H. Streeck is Director of the Institue of HIV Research at the University Hospital Essen. He studied at Charité in Berlin and received is MD at Friedrich-Wilhelm University Bonn. From 2006 to 2009 he spent his Postdoctoral Fellowship at the Partner AIDS Research Center and was appointed Assistant Professor at the Ragon Institute of the Massachusetts General Hospital affiliated with the MIT and Harvard. In 2012, he became Leader of the Cellular Immunology Department of the US Military HIV Research Program (MHRP) and Assistance Professor for ‘Emerging Infectious Diseases’ at the Uniformed Services University of Health Sciences in Washington D.C. In 2015 he was appointed full professor at the University Hospital Essen.
At the echo Hendrik Streeck will be giving a presentation on ‚HIV and Lymphoma‘.

TemmingPetra Temming, MDConsultant Pediatrician, Clinic for Pediatric Oncology, University Hospital Essen
Petra Temming studied medicine in Lübeck and Barcelona and graduated from Medical School in 2003. She performed her training in Pediatrics and Pediatric Hematology and Oncology in Lübeck, London and Hamburg. Currently she holds a position as a Consultant for Pediatrics and Pediatric Hematology and Oncology at the Kinderklinik III in Essen. Her research focuses on pediatric embryonal tumors and her main interest is retinoblastoma. She is designated study coordinator for clinical studies on retinoblastoma in Germany and Austria by  The So­cie­ty for Pa­ed­ia­tric On­co­lo­gy and Hae­ma­to­lo­gy (GPOH).
At the echo Petra Temming will be giving a presentation on ‚Retinoblastoma‘.

thakur_9500%20beschnittenBasant Thakur, Ph.D.Group Leader in experimental molecular research, Clinic for Pediatric Oncology, University Hospital Essen

After finishing his studies in Biotechnology in India, Dr. Thakur started his scholarship for Ph.D. in Medical School Hannover (2004-2008). He focused on the factors regulating the mRNA stability of cytokines involved in inflammation and cancer. For his postdoc in
the lab of Dr. Karl Welte (2008), he worked on addressing the role of tumor suppressor p53 in pediatric AML. In 2015, he was appointed faculty at Weill Cornell Medical College, New York, where he discovered the presence of double-stranded DNA in extracellular
vesicles (exosomes) released by cancer cells. Since 2016, he is appointed as a group leader at Clinic for Pediatric Oncology, Essen. His primary focus is to establish the functional and biomarker relevance of plasma exosomes isolated from pediatric AML and medulloblastoma patients. At the echo Basant Thakur will be giving a presentation on
‚Functional and biomarker potential of plasma exosomes in pediatric cancer‘.


Advertisements